| 1 |
A case of erythrodermic psoriasis in which adalimumab injection sites are preserved |
|
| | Ilknur Ozcan,Ayse Serap Karadag,Eylem Ceren,Busra Demirci,Filiz Cebeci | | | Dermatologic Therapy. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Classification and mitigation of negative injection experiences with biologic medications |
|
| | Jennifer M. Fernandez,Steven Madsen,Jeffrey M. Krase,Vivian Y. Shi | | | Dermatologic Therapy. 2020; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic |
|
| | Yang Lo,Hsien-Yi Chiu,Tsen-Fang Tsai | | | Molecular Diagnosis & Therapy. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Improvement of recalcitrant psoriatic lesions on the lower legs by changing the injection site of secukinumab from the abdomen to lower legs |
|
| | Kosuke Katsuo,Tetsuya Honda,Kenji Kabashima | | | The Journal of Dermatology. 2019; | | | [Pubmed] [Google Scholar] [DOI] | |
|
